Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis
Ling Chen
Abstract
Ling Chen
Abstract
Idiopathic pulmonary fibrosis is a chronic, progressive, and fatal fibrotic interstitial pneumonia with poor prognosis.There have been no effective pharmacologic therapies.In recent years, anti-fibrotic drugs such as pirfenidone and nidanib have been found.These drugs can prevent the disease from worsening, but do not improve it.Therefore, non-pharmacological therapies such as pulmonary rehabilitation, in recent years, have become the focus of research. Key words: Pulmonary fibrosis, idiopathic; Pulmonary rehabilitation
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Idiopathic pulmonary fibrosis is a chronic, progressive, and fatal fibrotic interstitial pneumonia with poor prognosis.There have been no effective pharmacologic therapies.In recent years, anti-fibrotic drugs such as pirfenidone and nidanib have been found.These drugs can prevent the disease from worsening, but do not improve it.Therefore, non-pharmacological therapies such as pulmonary rehabilitation, in recent years, have become the focus of research. Key words: Pulmonary fibrosis, idiopathic; Pulmonary rehabilitation
Key concepts: Medicine, Pirfenidone, Idiopathic pulmonary fibrosis, Pulmonary rehabilitation, Pulmonary fibrosis, Usual interstitial pneumonia, Interstitial pneumonia, Intensive care medicine